维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="ITO MK"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Lovastatin and extended release niacin combination product: the first drug combination for the management of hyperlipidemia显示文摘	Gupta EK Ito MK	2002	Heart Dis2002，4，2：	1
2	National Lipid Assoeia-tion recommendation for patient-recentered management of dyslipidemia part i-executive summary显示文摘	Jaeobson TA Ito MK Maki KC	2014	J Clin Lipi- dol2014，8，5：	1
3	Statin-associated pleiotropy:possible beneficial elects beyond cholesteml reduction显示文摘	Ito MK Talbert RI Tsimikas S	2006	J Pharmacothempy2006，26，7：	1
4	Statin-associated pleiotropy:possible beneficial effects beyond cholesterol reduction显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharmacotherapy2006，26，：	1
5	National Lipid Association recommenda- tions for patient-centered management of dyslipidemia : part l--executive sum- mary显示文摘	Jacobson TA Ito MK Maki KC	2014	J Clin Lipidol2014，8，5：	1
6	Statin-associated pleiotropy:possible beneficial effects beyond cholesterol reduction显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharmacotherapy2006，26，2：	1
7	Statin - associated pleiotropy : possible beneficial effects beyond cholesterol reduction 显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharmacotherapy2006，26，72：	1
8	National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary 显示文摘	Jacobson TA Ito MK Maki KC	2014	J Clin Lipidol2014，8，5：	1
9	Niacin-based therapy for dyslipidemia: past evidence and future advances 显示文摘	Ito MK	2002	Am J Manag Care2002，8，12：	1
10	Statin associated pleiotropy : possi- ble beneficial effects beyond cholesterol reduction 显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharmaco- therapy2006，26，：	1
11	Statin - associated pleiotropy: Possible benefical effects beyond cholesterol reduction 显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharmacotherapy2006，26，72：	1
12	National lipid association recommendations for patient-centered management of dyslipidemia:part 1--full report显示文摘	Jacobson TA Ito MK Maki KC	2015	J Clin Lipidol2015，9，2：	1
13	Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction显示文摘	Ito MK Talben RL Tsimikas S	2006	Pharmacotherapy2006，26，72：	1
14	Statin-associated pleiotropy:possible neneficial effects beyond cholesterol reduction显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharmacotherapy2006，26，72：	1
15	Statin-associated pleiotropy:pos-sible benefi-cial effects beyond cholesterol reduction显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharma-cotherapy2006，26，72：	1
16	National Lipid Association reeommendations for patient-centered management of dyslipid- emia: part 1 - executive summary显示文摘	Jacobson TA Ito MK Maki KC	2014	J Clin Lipidol2014，8，5：	1
17	National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-executive summary 显示文摘	Jacobson TA Ito MK Maki KC	2014	J Chn Lipidol2014，8，5：	1
18	Subretinal bleeding without choroidal neovascularization in pathologic myopia 显示文摘	Ohno MK Ito M Tokoto T	1996	Retina1996，16，3：	1
19	Statin-associated pleiotropy : possible beneficial effects beyond cholesterol reduction 显示文摘	Ito MK Talbert RL Tsimikas S	2006	Pharmacotherapy2006，26，72：	1
20	National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-- full report显示文摘	Jaeobson TA Ito MK Maki KC	2015	J Clin Lipidol2015，9，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示